The Baylor Scott & White Health difference
If you or your loved one is facing a genitourinary cancer (GU cancer) diagnosis, turn to the experts at the Genitourinary Cancer Research and Treatment Center, an integral part of Baylor Scott & White Charles A. Sammons Cancer Center – Dallas. A diagnosis of GU cancer can be overwhelming, but our dedicated team of experts will apply the best medicine, treatments and research to bring hope and healing to our patients and their caregivers.
Cancers treated
Our comprehensive Genitourinary Cancer Center in Dallas treats more GU cancer patients than any other cancer program in the region and excels in the management of complex and advanced high-risk cases, so you can rest assured you are being cared for by the most capable and experienced team in North Texas.
Our team specializes in the treatment of cancers of the GU tract, including:
Genitourinary cancer treatment options
Every patient is unique and deserves a personalized plan of care. Treatment plans for patients will be determined by their care team based on age, medical history, type and stage of GU cancer, and personal preferences. Patients in Dallas can be treated with any combination of:
- Surgery
- Chemotherapy
- Radiation therapies
- Active surveillance
- Pain management
- Immunotherapy
- Personalized genetic profile
- Clinical trials
Our team approach
To ensure patients are receiving quality care at all stages of their GU cancer diagnosis, our team of Dallas cancer care experts participate in multidisciplinary cancer conferences to collaboratively discuss, evaluate and recommend the most appropriate treatment plan for each patient.
In addition to physician and nursing experts, the care team at the Genitourinary Cancer Research and Treatment Center in Dallas also includes specialists in the following areas:
Texas Immuno-Oncology Biorepository (TIOB)
The Texas Immuno-Oncology Biorepository (TIOB) is a research facility that collects, catalogs and stores samples of biological material, such as urine, blood, stool, tissue, cells, DNA, RNA and protein, in an effort to improve our understanding of cancer.